Legend Biotech (NASDAQ:LEGN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Legend Biotech Stock (NASDAQ: LEGN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.22M
Day Range	- - -
52 Wk Range	36.92 - 70.13
Market Cap	$7.40B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	16.37%
Days to Cover	10.15

Recent News

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

Johnson & Johnson and Legend Biotech presented new data from the Phase 3 CARTITUDE-4 study, showing Carvykti significantly extends survival in multiple myeloma patients, reducing the risk of death by 45% compared to standard therapies.

Vandana Singh

Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?

Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding in Legend By Molly Wen

The Bamboo Works

Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?

Top performers last week: $WBD up 18.28%, $MSTR up 16.74%, $DHI up 12.91%, $COIN up 12.39%, $OQL up 7.89%, $UNH up 7.84%, $STT up 7.21%, $LEN up 7.07%, $TOST up 7.05%, $EPAM up 6.97%. Are they in your portfolio?

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.22M
Day Range	- - -
52 Wk Range	36.92 - 70.13
Market Cap	$7.40B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	16.37%
Days to Cover	10.15

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Legend Biotech (LEGN) stock?

You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.

View our list of the best stock brokerages

Who are Legend Biotech (LEGN) competitors?

Other companies in Legend Biotech’s space includes: Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Legend Biotech (LEGN) stock?

Legend Biotech has a consensus price target of $81.88.

What is the current price for Legend Biotech (LEGN)?

The stock price for Legend Biotech (NASDAQ: LEGN) is $40.14 last updated November 20, 2024 at 4:00 PM EST.

Does Legend Biotech (LEGN) pay a dividend?

There are no upcoming dividends for Legend Biotech.

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

Legend Biotech’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Legend Biotech (LEGN) going to split?

There is no upcoming split for Legend Biotech.

What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Legend Biotech

Legend Biotech (LEGN) Forecast